Ribometrix, headquartered in Durham, North Carolina, is a biotechnology company leveraging world-leading expertise in three-dimensional structural analysis of RNA as the foundation of its proprietary drug discovery platform. This platform enables the identification of novel small molecules that modulate the function of RNA and proteins associated with human disease. Ribometrix’ value creation strategy is built around developing an internal pipeline of drug candidates and partnerships with the leading biopharmaceutical companies. Ribometrix is backed by a syndicate of blue-chip venture investors. 

Information Technology

Ribometrix

Ribometrix's headquarters in Durham, NC, United States

Allen Zhang

Katie Warner

Orshi Kocsis

Jonathan Kearns

Murty Changalvala

Raquel Martinez Chacin

Ramamurty Changalvala

Kevin Weeks

Matt Smola

Caleb D. Sutherland

Laurel Shambley

Brittani Patterson

Mike Dial

Mike Clayman

Hakan Goker

Mike Ross

John Schneekloth

William S. Marshall

The Research and Development team at Ribometrix focuses on harnessing advanced structural analysis of RNA to drive the discovery of innovative drug candidates. This multidisciplinary group, consisting of experts in medicinal chemistry, RNA biology, and translational medicine, collaborates to translate scientific insights into actionable therapeutic strategies, advancing the company’s internal drug pipeline and fostering partnerships with leading biopharmaceutical firms. Their goal is to develop small molecules that effectively modulate RNA and protein functions linked to human diseases.

Research and Development

The Leadership Team at Ribometrix is responsible for setting the strategic direction and overall vision of the company, ensuring alignment between its innovative drug discovery platform and market opportunities. This team, comprising key executives like the CEO and VPs, oversees crucial functions such as operations, financial management, and scientific development in RNA biology, driving the internal pipeline of drug candidates and fostering partnerships with leading biopharmaceutical companies. Their collaborative efforts aim to advance Ribometrix's mission of developing novel therapeutics to address human diseases.

Leadership Team

The Finance and Accounting team at Ribometrix is responsible for managing the company's financial operations, ensuring accurate reporting and compliance with regulations. They oversee budgeting, forecasting, and financial analysis to support strategic decision-making and facilitate the growth of Ribometrix's innovative drug discovery platform. This team plays a crucial role in maintaining financial health and securing investments to advance the company's pipeline and partnerships.

Finance and Accounting

Ribometrix

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Finance and Accounting

Offices

Ribometrix

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Finance and Accounting

Offices

Related companies